acetylcysteine
(Acetylcysteine)Almaject, Inc.
8 results
dexrazoxane
(Dexrazoxane for Injection)Almaject, Inc.Usage: Dexrazoxane for Injection is indicated to reduce cardiomyopathy incidence and severity in women with metastatic breast cancer receiving doxorubicin, after a cumulative dose of 300 mg/m², who will continue doxorubicin therapy for tumor control. It should not be used at the start of doxorubicin treatment.dexrazoxane
(Dexrazoxane for Injection)Almaject, Inc.Usage: Dexrazoxane for Injection is indicated to reduce the incidence and severity of cardiomyopathy in women with metastatic breast cancer receiving cumulative doxorubicin doses of 300 mg/m² or more, who will continue doxorubicin therapy for tumor control. It should not be used at the start of doxorubicin therapy.metoprolol tartrate - metoprolol tartrate injection, solution
(Metoprolol Tartrate)Almaject, Inc.midazolam - midazolam injection, solution
(Midazolam)Almaject, Inc.midazolam - midazolam injection, solution
(Midazolam)Almaject, Inc.regadenoson
(Regadenoson)Almaject, Inc.Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to perform adequate exercise stress testing.temsirolimus
(Temsirolimus Injection)Almaject, Inc.Usage: Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma.